MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Icon ( ($ICLR) ) has shared an announcement. On November 12, 2025, ICON plc announced that its CEO, Barry Balfe, and CFO, Nigel Clerkin, will ...

Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 9:00 ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 ...

Dr. Harshan Lamabadusuriya started his schooling at Richmond College Galle and then spent a couple of years at S. Thomas’ ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock fell 4% Monday after the company announced it would discontinue its Phase 3 ICoN-1 clinical trial for nontuberculous mycobacterial (NTM) lung ...

Two Smith College alums—author and feminist icon Gloria Steinem ’56 and lawyer and civil rights advocate Deborah N. Archer ...

Jamie Roberts will be a feature on television screens throughout November, working for TNT Sports as part of their autumn ...

UC President James B. Milliken has awarded the university’s highest honor to Joan and Sanford I. Weill in recognition of ...

Methi (fenugreek) water is a traditional Indian remedy for the gut. Explore how its rich fibre content helps prevent gut ...

Once, the humble carrot, celebrated for its beta-carotene and vitamin A, was considered the go-to food for healthy eyes. Today, however, a new trend is taking shape: chewable, fruit-flavoured gummy vi ...

Carol Saffran started taking Ozempic a year ago to regulate her blood sugar after other medications were ineffective. She was prediabetic, a condition in which blood sugar levels are higher than ...